Transmission of SARS-CoV-2: still up in the air - Authors' reply
- PMID: 35123690
- PMCID: PMC8813063
- DOI: 10.1016/S0140-6736(21)02795-1
Transmission of SARS-CoV-2: still up in the air - Authors' reply
Conflict of interest statement
DF has served on advisory boards for Pfizer, AstraZeneca, Sanofi, and Seqirus vaccines and has provided legal advice to the Elementary Teachers Federation of Ontario and Ontario Nurses’ Association. RS has received consulting fees from Sempra Energy and Lysentech; honoraria from the International Antiviral Society–USA; has a patent application submitted for oral anti-coronavirus compounds; has been on a data safety monitoring board for Merck and Vir Biotechnology; has a voluntary (unpaid) leadership role in the Conference on Retroviruses and Opportunistic Infections Foundation Board of Directors and International Antiviral Society–USA; and has stocks or shares in Antiva Biosciences, CytoDyn, and Arcturus. All other authors declare no competing interests.
Comment on
-
Ten scientific reasons in support of airborne transmission of SARS-CoV-2.Lancet. 2021 May 1;397(10285):1603-1605. doi: 10.1016/S0140-6736(21)00869-2. Epub 2021 Apr 15. Lancet. 2021. PMID: 33865497 Free PMC article. No abstract available.
References
-
- US Centers for Disease Control and Prevention Science brief: SARS-CoV-2 and surface (fomite) transmission for indoor community environments. April 5, 2021. https://www.cdc.gov/coronavirus/2019-ncov/more/science-and-research/surf... - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous